A method to confer Protein L binding ability to any antibody fragment

References

• Graslund S, Nordlund P, Weigelt J, Hallberg BM, Bray J, Gileadi O, Knapp S, Oppermann U, Arrowsmith C, Hui R, et al. Protein production and purification. Nat Methods 2008; 5:135–46; PMID:18235434; http://dx.doi.org/10.1038/nmeth.f.202
   PubMed Web of Science ®Google Scholar
• Das D, Allen TM, Suresh MR. Comparative evaluation of two purification methods of anti-CD19-c-myc-His6-Cys scFv. Protein Expr Purif 2005; 39:199–208; PMID:15642471; http://dx.doi.org/10.1016/j.pep.2004.10.007
   PubMed Web of Science ®Google Scholar
• Bjorck L. Protein L. A novel bacterial cell wall protein with affinity for Ig L chains. J Immunol 1988; 140:1194–7; PMID:3125250
   PubMed Web of Science ®Google Scholar
• Myhre EB, Erntell M. A non-immune interaction between the light chain of human immunoglobulin and a surface component of a Peptococcus magnus strain. Mol Immunol 1985; 22:879–85; PMID:3930951; http://dx.doi.org/10.1016/0161-5890(85)90073-2
   PubMed Web of Science ®Google Scholar
• Nilson BH, Solomon A, Bjorck L, Akerstrom B. Protein L from Peptostreptococcus magnus binds to the kappa light chain variable domain. J Biol Chem 1992; 267:2234–9; PMID:1733930
   PubMed Web of Science ®Google Scholar
• di Tommaso A, Juste MO, Martin-Eauclaire MF, Dimier-Poisson I, Billiald P, Aubrey N. Diabody mixture providing full protection against experimental scorpion envenoming with crude Androctonus australis venom. J Biol Chem 2012; 287:14149–56; PMID:22375011; http://dx.doi.org/10.1074/jbc.M112.348912
   PubMed Web of Science ®Google Scholar
• Aubrey N, Devaux C, Sizaret PY, Rochat H, Goyffon M, Billiald P. Design and evaluation of a diabody to improve protection against a potent scorpion neurotoxin. Cell Mol Life Sci 2003; 60:617–28; PMID:12737321; http://dx.doi.org/10.1007/s000180300053
   PubMed Web of Science ®Google Scholar
• Royce J. An industrial platform solution for antibody fragment purification. BioProcess International 2015; 13:6
   Google Scholar
• Kastern W, Sjobring U, Bjorck L. Structure of peptostreptococcal protein L and identification of a repeated immunoglobulin light chain-binding domain. J Biol Chem 1992; 267:12820–5; PMID:1618782
   PubMed Web of Science ®Google Scholar
• Bottomley SP, Beckingham JA, Murphy JP, Atkinson M, Atkinson T, Hinton RJ, Gore MG. Cloning, expression and purification of Ppl-1, a kappa-chain binding protein, based upon protein L from Peptostreptococcus magnus. Bioseparation 1995; 5:359–67; PMID:8767928
   PubMedGoogle Scholar
• Nilson BH, Logdberg L, Kastern W, Bjorck L, Akerstrom B. Purification of antibodies using protein L-binding framework structures in the light chain variable domain. J Immunol Methods 1993; 164:33–40; PMID:8360508; http://dx.doi.org/10.1016/0022-1759(93)90273-A
   PubMed Web of Science ®Google Scholar
• Graille M, Stura EA, Housden NG, Beckingham JA, Bottomley SP, Beale D, Taussig MJ, Sutton BJ, Gore MG, Charbonnier JB. Complex between Peptostreptococcus magnus protein L and a human antibody reveals structural convergence in the interaction modes of Fab binding proteins. Structure 2001; 9:679–87; PMID:11587642; http://dx.doi.org/10.1016/S0969-2126(01)00630-X
   PubMed Web of Science ®Google Scholar
• Housden NG, Harrison S, Housden HR, Thomas KA, Beckingham JA, Roberts SE, Bottomley SP, Graille M, Stura E, Gore MG. Observation and characterization of the interaction between a single immunoglobulin binding domain of protein L and two equivalents of human kappa light chains. J Biol Chem 2004; 279:9370–8; PMID:14668335; http://dx.doi.org/10.1074/jbc.M312938200
   PubMed Web of Science ®Google Scholar
• Graille M, Stura EA, Bossus M, Muller BH, Letourneur O, Battail-Poirot N, Sibai G, Gauthier M, Rolland D, Le Du MH, et al. Crystal structure of the complex between the monomeric form of Toxoplasma gondii surface antigen 1 (SAG1) and a monoclonal antibody that mimics the human immune response. J Mol Biol 2005; 354:447–58; PMID:16242717; http://dx.doi.org/10.1016/j.jmb.2005.09.028
   PubMed Web of Science ®Google Scholar
• Muzard J, Adi-Bessalem S, Juste M, Laraba-Djebari F, Aubrey N, Billiald P. Grafting of protein L-binding activity onto recombinant antibody fragments. Anal Biochem 2009; 388:331–8; PMID:19268418; http://dx.doi.org/10.1016/j.ab.2009.02.035
   PubMed Web of Science ®Google Scholar
• Lefranc MP, Giudicelli V, Ginestoux C, Jabado-Michaloud J, Folch G, Bellahcene F, Wu Y, Gemrot E, Brochet X, Lane J, et al. IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res 2009; 37:D1006–12; PMID:18978023; http://dx.doi.org/10.1093/nar/gkn838
   PubMed Web of Science ®Google Scholar
• Martin AC. Accessing the Kabat antibody sequence database by computer. Proteins 1996; 25:130–3; PMID:8727325; http://dx.doi.org/10.1002/(SICI)1097-0134(199605)25:1%3c130::AID-PROT11%3e3.3.CO;2-Y
   PubMed Web of Science ®Google Scholar
• Graille M, Harrison S, Crump MP, Findlow SC, Housden NG, Muller BH, Battail-Poirot N, Sibai G, Sutton BJ, Taussig MJ, et al. Evidence for plasticity and structural mimicry at the immunoglobulin light chain-protein L interface. J Biol Chem 2002; 277:47500–6; PMID:12221088; http://dx.doi.org/10.1074/jbc.M206105200
   PubMed Web of Science ®Google Scholar
• Beckingham JA, Bottomley SP, Hinton R, Sutton BJ, Gore MG. Interactions between a single immunoglobulin-binding domain of protein L from Peptostreptococcus magnus and a human kappa light chain. Biochem J 1999; 340 (Pt 1):193–9; PMID:10229674; http://dx.doi.org/10.1042/bj3400193
   PubMed Web of Science ®Google Scholar
• Zahid M, Loyau S, Bouabdelli M, Aubrey N, Jandrot-Perrus M, Billiald P. Design and reshaping of an scFv directed against human platelet glycoprotein VI with diagnostic potential. Anal Biochem 2011; 417:274–82; PMID:21771576; http://dx.doi.org/10.1016/j.ab.2011.06.036
   PubMed Web of Science ®Google Scholar
• Lefranc MP. Unique database numbering system for immunogenetic analysis. Immunol Today 1997; 18:509; PMID:9386342; http://dx.doi.org/10.1016/S0167-5699(97)01163-8
   PubMedGoogle Scholar
• Mousli M, Devaux C, Rochat H, Goyffon M, Billiald P. A recombinant single-chain antibody fragment that neutralizes toxin II from the venom of the scorpion Androctonus australis hector. FEBS Lett 1999; 442:183–8; PMID:9928998; http://dx.doi.org/10.1016/S0014-5793(98)01647-0
   PubMed Web of Science ®Google Scholar
• Devaux C, Moreau E, Goyffon M, Rochat H, Billiald P. Construction and functional evaluation of a single-chain antibody fragment that neutralizes toxin AahI from the venom of the scorpion Androctonus australis hector. Eur J Biochem 2001; 268:694–702; PMID:11168408; http://dx.doi.org/10.1046/j.1432-1327.2001.01923.x
   PubMedGoogle Scholar